Your browser doesn't support javascript.
loading
Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions.
Kvasnicka, Tomas; Malikova, Ivana; Zenahlikova, Zuzana; Kettnerova, Karolína; Brzezkova, Radka; Zima, Tomas; Ulrych, Jan; Briza, Jan; Netuka, Ivan; Kvasnicka, Jan.
Afiliação
  • Kvasnicka T; Thrombotic Centre of Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, Karlovo Namesti 32, 121 11 Prague 2. Czech Republic.
  • Malikova I; Central Hematological Laboratory of Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine of Charles University, Prague. Czech Republic.
  • Zenahlikova Z; Thrombotic Centre of Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, Karlovo Namesti 32, 121 11 Prague 2. Czech Republic.
  • Kettnerova K; Thrombotic Centre of Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, Karlovo Namesti 32, 121 11 Prague 2. Czech Republic.
  • Brzezkova R; Thrombotic Centre of Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, Karlovo Namesti 32, 121 11 Prague 2. Czech Republic.
  • Zima T; Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine of Charles University, Prague. Czech Republic.
  • Ulrych J; 1st Department of Surgery, General University Hospital and 1st Faculty of Medicine of Charles University, Prague, . Czech Republic.
  • Briza J; 1st Department of Surgery, General University Hospital and 1st Faculty of Medicine of Charles University, Prague, . Czech Republic.
  • Netuka I; Institute for Clinical and Experimental Medicine, Cardiovascular Surgery Dept., Prague. Czech Republic.
  • Kvasnicka J; Thrombotic Centre of Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, Karlovo Namesti 32, 121 11 Prague 2. Czech Republic.
Curr Drug Metab ; 18(7): 636-642, 2017.
Article em En | MEDLINE | ID: mdl-28524005

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article